Paolo Usai-Satta*, Massimo Bellini, Mariantonia Lai, Francesco Oppia and Francesco Cabras Pages 164-172 (9)
The purpose of this review is to update our current knowledge of therapeutic approach of this disorder.
Method: A literature search for IBS therapy was carried out using the online databases of Pubmed, Medline and Cochrane.
Results: An ideal treatment begins by explaining this condition and providing reassurance to the patients. There is limited evidence for the efficacy, and tolerability of the therapies currently available for the treatment of IBS. There is also a limited availability of pharmacological agents licensed specifically for the treatment of IBS subtypes, although new agents have been recently proposed to this goal. Furthermore, patients often associate their complaints with the ingestion of foods containing FODMAPs (fermentable oligo-di-monosaccharides, and polyols) and gluten derivates and a personalized diet can be proposed. However, more severe symptoms can be associated with greater levels of psychosocial problems and a psychological approach and antidepressant drugs can be needed.
Conclusion: The treatment of IBS remains focused on treating the patient’s predominant, or most troublesome, symptoms. New promising treatments have recently become available for the treatment of IBS but long term studies are still needed.
Irritable bowel syndrome, constipation, pain, diarrhea, pharmacological agents, diet.
Gastroenterology Unit, Brotzu Hospital, Cagliari, Gastrointestinal Unit, Department of Gastroenterology, University of Pisa, Pisa, Gastroenterology Unit, Internal Medicine Department, University of Cagliary, Monserrato, Gastroenterology Unit, Brotzu Hospital, Cagliari, Gastroenterology Unit, Brotzu Hospital, Cagliari